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Background: Around 30–60% of patients with basilar artery occlusion (BAO) present
with coma, which is often considered as a hallmark of poor prognosis.
Aim: To examine factors that will help predict outcomes in patients with BAO comatose
on admission.
Methods: A total of 312 patients with angiography-proven BAO were analyzed. Comas
were assessed as Glasgow Coma Scale (GCS) of ≤8 or impaired level of consciousness
ascertained in the medical records. Outcomes were evaluated with the modified Rankin
Scale (mRS) over a phone call at 3 months. In our study, 53 patients were excluded due
to inadequate data on the level of consciousness.
Results: In total, 103/259 (39.8%) of BAO patients were comatose on admission.
Factors associated with acute coma were higher age, coronary artery disease,
convulsions, extent of early ischemia by posterior circulation Acute Stroke Prognosis
Early CT Score (pc-ASPECTS) < 8, absence of patent posterior collateral vasculature,
and occlusion over multiple segments of BA. A total of 21/103 (20.4%) of comatose
patients had a favorable outcome (mRS 0–3), and 12/103 (11.7%) had a good outcome
(mRS 0–2). Factors associated with a favorable outcome in comatose BAO patients were
younger age (p = 0.010), less extensive baseline ischemia (p = 0.027), recanalization
(p = 0.013), and avoiding symptomatic intracranial hemorrhage (sICH) (p = 0.038).
Factors associated with the poorest outcome or death (mRS 5–6) were older age
(p= 0.001), diabetes (p= 0.022), atrial fibrillation (p= 0.016), lower median GCS [4 (IQR
3.6) vs. 6 (5–8); p = 0.006], pc-ASPECTS < 8 (p = 0.003), unsuccessful recanalization
(p= 0.006), and sICH (p= 0.010). Futile recanalization (mRS 4–6) was significantly more
common in comatose patients (49.4 vs. 18.5%, p < 0.001).
Conclusions: One in five BAO patients with acute coma had a favorable outcome. Older
patients with cardiovascular comorbidities and already existing ischemic lesions before
reperfusion therapies tended to have a poor prognosis, especially if no recanalization is
achieved and sICH occurred.
Keywords: basilar artery, outcome, coma, stroke, recanalization therapy
Ritvonen et al. Basilar Artery Occlusion and Coma
INTRODUCTION
Basilar artery occlusion (BAO) accounts for 1% of all ischemic
strokes but is still often considered the most appalling form of
stroke (1, 2). The clinical picture of BAO varies greatly, and
roughly 30–60% of patients present with the most shocking
state, being comatose on admission (3–10). This initial coma
or imminent locked-in state results typically from dense
pontine ischemia, which anatomically encompasses essential
areas forming the reticular activating system responsible for
sustaining consciousness and motor pyramidal tracts (1, 11).
Indeed, in the face of the poor outcome reported to be
associated with progressing pontine ischemia and depressed
consciousness, acute coma in BAO, a discrete clinical entity, is
one of the most challenging emergencies to be coped with by the
emergency department (ED) attending neurologists and other
acutologists (6, 12). However, it has also been reported that,
with successful recanalization therapy, up to 15–26% of these
patients presenting comatose on admission will eventually have a
favorable outcome [modified Rankin Scale (mRS) 0–3] (6, 13, 14).
Which clinical signs, imaging characteristics and presumptive
biomarkers could be used to assist in early risk stratification
supporting initial management decisions, i.e., aggressive or de-
escalated supportive therapy, and guide pressing interactions
with the close ones?Mortality among intubated andmechanically
ventilated stroke patients is high, yet the treatment decisions
are not simple. It is one of the greatest challenges in the
acute setting to estimate the prognostic potential to life “worth
living” and the extent of treatments worth giving (15). Coma
on presentation has been one negative prognostic marker to
influence such decisions, especially regarding invasive therapies
(4). Neurologists managing these patients often lack urgent
directions in making these fundamental care decisions, for which
this analysis was performed.
BAO carries high mortality of up to 95% if recanalization does
not occur (1, 2, 7). Pallesen et al. (6) reported brainstem ischemia
to be an important factor in predicting mortality in comatose
BAO patients, which underlines the need for the early reversal
of BAO with intravenous thrombolysis (IVT) or endovascular
treatment (EVT). However, according to our knowledge, the
baseline characteristics potentially predicting the outcome after
BAO patients presenting with coma have never been systemically
examined. This led us to carry out the present investigation in
our sizable consecutive cohort of BAO patients treated with IVT
and/or EVT.
AIM OF THE STUDY
We set out to examine factors that would help in predicting




A total of 312 consecutive patients with angiography-proven
BAO, treated between June 1995 and September 2019 in the
Department of Neurology, Helsinki University Hospital, were
analyzed. Coma was assessed as Glasgow Coma Scale (GCS)
of ≤8 either in emergency medical service (EMS) records or
at ED (whichever is lowest) before initiation of recanalization
therapy. In subjects where GCS was not routinely reported, the
level of consciousness was ascertained from the medical records
describing the detailed responsiveness of the patient. In essence,
the patient was defined as “comatose” if the level of consciousness
was documented to be clearly impaired or if there was a need for
intubation due to a low level of consciousness. We do performed
endovascular intervention in the majority of the cases under
conscious sedation, and if a patient was intubated only to perform
neurointerventional therapy or neuroimaging, and not because
of the low level of consciousness, the patient was not defined as
“comatose.” As the level of consciousness on presentation could
not be ascertained reliably due to insufficient EMS records and/or
patient medical records, 53 patients were excluded.
Patient data, including also the 3-month follow-up
assessment, were collected as a part of routine hospital care, and
approval from an ethics committee or informed consent were
thus not required to collect and reconcile retrospective clinical
data in our institution. National Institutes of Health Stroke Scale
(NIHSS) score is obtained for all acute recanalization patients
on admission but since its determination may be interfered with
by a low level of consciousness and possible anesthetic sedation,
we excluded it from the analyses. The BAO “phenotype” was
defined as a sudden or progressive onset of symptoms, as
previously described (1).
Imaging
Imaging was performed on admission for all patients with either
computed tomography (CT) or magnetic resonance imaging
(MRI) accompanied by CT angiography (CTA), MR angiography
(MRA), or digital subtraction angiography (DSA). Control
imaging was obtained ∼24 h after treatment and whenever
clinical deterioration occurred. The extent of baseline ischemia
was evaluated with the posterior circulation Acute Stroke
Prognosis Early CT Score (pc-ASPECTS) (16) (Figure 1).
Occlusion length was dichotomized to either “long,”
consisting of two or more basilar artery segments (proximal,
middle, and distal), or “short,” consisting of one segment.
Whether occlusion extended to the vertebral artery (VA) was
also analyzed. Recanalization was assessed from controlled
angiography images and dichotomized as partial to complete
[thrombolysis in myocardial infarction (TIMI) score 2–3] or nil
to minimal (TIMI 0–1) (17). Futile recanalization was defined as
successful recanalization with no clinical benefit demonstrated
as an mRS score 4–6 at 3 months (18).
Collateral vasculature was assessed from baseline angiography
images by identifying the presence and number of posterior
communicating arteries (PCom) and the presence of at least
one superior cerebellar artery (SCA) and posterior cerebral
artery (PCA). Symptomatic intracranial hemorrhage (sICH) was
defined according to European Cooperative Acute Stroke Study
II (ECASS II) criteria (19). Radiological data were analyzed by an
experienced neuroradiologist (HS/PV/OS).
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FIGURE 1 | Baseline ischemic changes and basilar artery occlusion in computer tomography. (A) A 69-year-old woman was comatose on admission (GCS 4) and
diagnosed with basilar artery occlusion. This baseline CT scan shows extensive ischemic changes in both cerebellar hemispheres and bilaterally in pons. Overall
pc-ASPECTS was 5. A dense basilar artery is also seen. Patient received IVT but died on day 3 of hospitalization. (B) A 65-year-old woman was comatose on
admission (GCS 6). Baseline CTA shows long BAO over mid- and caudal BA. IVT was administered and subsequent mechanical thrombectomy was performed with
successful recanalization. Patient recovered with a 3-month mRS of 1.
Outcome
The outcome was measured with an mRS obtained at 3 months
by a certified neurologist. It was then dichotomized as favorable
(mRS 0–3) vs. poor (mRS 4–6). AnmRS score of 3 was considered
still favorable due to the abysmal natural course of BAO, and this
is unlike anterior circulation, where an mRS 0–2 is most often
regarded as a favorable outcome. Secondary outcome measures
were a good outcome (mRS 0–2) and being bedridden or dead
(mRS 5–6) at 3 months. Mortality was also analyzed.
Statistical Analyses
Dichotomous variables were analyzed with Pearson’s chi-square
test or Fisher’s exact test when appropriate. The distribution
of continuous variables was tested for normality and analyses
were performed with t-test for normally distributed or with
Mann-Whitney U-test for non-normally distributed variables.
Multivariable analysis of factors associated with coma was made
with a stepwise backward logistic regression model, and variables
with probability (p) value < 0.1 in univariate model were
included in order to avoid selection bias and overfitting. For
factors associated with favorable outcomes in comatose patients,
no multivariable model was possible to construct due to the
small number of subjects. Therefore, only the univariate model
was built. SPSS 25 (IBM, Armonk, NY, USA) was used in all
statistical analyses.
RESULTS
Among the cohort of 259 BAO patients, 103 (39.8%) presented
comatose (GCS ≤ 8) on admission. 85/103 (82.5%) of comatose
patients were intubated. For all of them, the reason for
intubation was a poor clinical condition or securing the airway
because of impaired consciousness. In total, 35 patients (13.5%)
had baseline imaging with MRI, and the remaining majority
underwent CT scans. Patient characteristics are shown inTable 1.
Comatose patients tended to be older, had more frequent
histories of coronary artery disease and myocardial infarctions,
and were more likely to present with convulsions. Regarding
brain imaging findings of the posterior circulation area, patients
with initial coma had more often extensive baseline ischemic
lesions as evaluated with pc-ASPECTS < 8 (29.1 vs. 11.6%,
p< 0.001) and more often radiological signs of bilateral ischemia
(35.3 vs. 14.5%, p < 0.001).
In vascular imaging of the posterior circulation, collateral
circulation was less complete in comatose patients as compared
to non-comatose patients with absence of patent PComs of the
circle of Willis in 29.0 vs. 13.6% (p = 0.003) and absence of
SCAs in 42.0 vs. 22.4% (p = 0.001), respectively. Comatose
patients also had multiple segments (≥2) of BA occluded and
a higher incidence of occlusions extending to the vertebral
artery (VA) (Table 1).
There was no difference in the rate of EVT or IVT
between comatose and non-comatose patients, and the vast
majority underwent IVT (90.3%). There were only three
patients not treated with recanalization therapy. In detail,
there was one patient with spontaneous recanalization in
DSA and 3-month mRS 3, one patient with EVT attempt
but no successful thrombectomy due to difficult stenosis and
no access with thrombectomy device (mRS 6), and another
with only IVT bolus administered but discontinued infusion
due to a history of malignancy (mRS 4). Treatment delays
did not differ between comatose and non-comatose BAO
patients (Table 1).
In multivariable analysis (Table 2) factors independently
associated with acute coma in BAO, patients were of older age,
had a history of coronary artery disease, convulsions, presence
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TABLE 1 | Characteristics of comatose vs. non-comatose patients at presentation.
n (%)/median (IQR) All (n = 259) Non-comatose (n = 156, 60.2%) Comatose (n = 103, 39.8%) p
Demographic and clinical characteristics
Male sex 169 (65.3%) 106 (67.9%) 63 (61.2%) 0.262
Age (years) 68 (59–77) 64 (58–75) 73 (63–79) <0.001
Diabetes 42 (16.2%) 24 (15.4%) 18 (17.5%) 0.655
Atrial fibrillation 60 (23.2%) 31 (19.9%) 29 (28.2%) 0.122
Hypertension 149 (57.5%) 85 (54.5%) 64 (62.1%) 0.223
Dyslipidemia 106 (40.9%) 64 (41.0%) 42 (40.8%) 0.968
Chronic heart failure 22 (8.5%) 10 (6.4%) 12 (11.7%) 0.139
Coronary artery disease 46 (17.8%) 21 (13.5%) 25 (24.3%) 0.026
History of myocardial infarction 26 (10.0%) 11 (7.1%) 15 (14.6%) 0.049
Previous stroke 63 (24.3%) 38 (24.4%) 25 (24.3%) 0.987
Sudden onset phenotype 214 (82.6%) 125 (80.1%) 89 (86.4%) 0.192
Prodromal symptoms 56 (21.6%) 37 (23.7%) 19 (18.4%) 0.313
Convulsions 37 (14.3%) 12 (7.7%) 25 (24.3%) <0.001
Radiological parameters
pc-ASPECTS < 8 48 (18.6%) 18 (11.6%) 30 (29.1%) <0.001
Bilateral ischemia 58 (22.8%) 22 (14.5%) 36 (35.3%) <0.001
Brainstem ischemia 48 (18.9%) 24 (15.8%) 24 (23.5%) 0.122
No patent PComs 49 (19.8%) 20 (13.6%) 29 (29.0%) 0.003
2 PComs 132 (53.4%) 89 (60.5%) 43 (43.0%) 0.007
At least one patent PCA 233 (94.3%) 138 (93.9%) 95 (95.0%) 0.708
At least one patent SCA 172 (69.6%) 114 (77.6%) 58 (58.0%) 0.001
Long BAO (≥2 segments) 100 (40.0%) 47 (31.5%) 53 (52.5%) 0.001
BAO exceeding to VA 59 (23.7%) 27 (18.1%) 32 (32.0%) 0.012
Treatments
IVT 234 (90.3%) 141 (90.4%) 93 (90.3%) 0.980
EVT 75 (29.0%) 45 (28.8%) 30 (29.1%) 0.961
IVT + EVT 53 (20.5%) 32 (20.5%) 21 (20.4%) 0.981
Time delays (min)
OTT 252 (138–720) 238 (125–780) 282 (158–640) 0.334
SDT 155 (78–451) 152 (75–474) 158 (85–371) 0.659
DTN 51 (25–195) 85 (38–180) 65 (30–185) 0.060
Data available in >95% for all parameters. IQR, interquartile range; pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early CT Score; PCom, posterior communicating artery;
PCA, posterior cerebral artery; SCA, superior cerebellar artery; BAO, basilar artery occlusion; VA, vertebral artery; IVT, intravenous thrombolysis; EVT, endovascular treatment; OTT,
Onset-to-treatment time, SDT, symptom-to-door time; DTN, Door-to-needle time.
Statistically significant p-values (<0.05) are bolded.
of extensive baseline ischemia, absence of PComs and SCAs, and
long BA occlusion.
Initial coma was associated with poor outcome, and 79.6%
of comatose patients had an mRS 4–6 at 3 months compared
to 38.4% among non-comatose patients (p < 0.001). Overall,
59.2% of comatose patients died within 3 months (Table 3), and
72.8% of patients with initial coma were either bedridden or
died (mRS 5–6) at 3 months, which compared to the 28.5% of
non-comatose patients (p < 0.001). Of the comatose patients,
13.6% had an mRS of 5 at 3 months. However, up to 20.4% of
comatose patients still had a favorable outcome (mRS 0–3), and
11.7% had a good outcome ofmRS 0–2 at 3months. There was no
significant difference in rates of recanalization between comatose
and non-comatose patients, but futile recanalization (mRS 4–6)
was significantly more common in comatose patients (49.4 vs.
18.5%, p< 0.001). There was a trend toward a higher rate of post-
treatment sICH in comatose patients (13.9 vs. 7.8%), but this was
not statistically significant (p= 0.117).
An exact GCS score was available for 83/103 of comatose
patients. A total of 19 patients had GCSs scores of three. The GCS
was four in 18 patients, five in 15 patients, six in 11 patients, and
seven in 14 patients. Only six patients had GCS score of eight. In
total, 3/19 (15.8%) of patients with a GCS score of three had an
mRS 0–3 at 3 months. The rest of these patients (16/19, 84.2%)
had the poorest outcome of an mRS of 5–6, and 13 of them
(68.4%) were dead at 3 months. Half of the patients with GCS
score of eight had an mRS 0–3 at 3 months, one died, and two
had the poorest outcome (mRS 5–6).
Characteristics associated with favorable outcomes in patients
with initial coma are shown in Table 4. Patients with favorable
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3-month outcome were younger [median age 65 (IQR 57–74)
vs. 74 (66–80) years, p = 0.010] and displayed less frequent
extensive baseline ischemic lesions (pc-ASPECTS < 8 in 9.5 vs.
34.1%, p = 0.027) compared with patients with an outcome
mRS of 4–6. Other demographic or clinical characteristics did
not differ between the outcomes of comatose patients, nor
did the radiological surrogates of vascular collateralization.
Recanalization was a necessary requirement for a favorable
outcome (i.e., mRS 0–3) in all but two patients (in 19/21).
None of the patients that achieved a favorable outcome had
sICH (Table 4).
Factors predicting the worst possible outcome, projected being
bedridden or dead, in a univariate model are shown in Table 5.
Patients with a 3-month mRS 5–6 were older, presented with
diabetes and atrial fibrillation more frequently, presented with
lower median GCS score [median 4 (IQR 3–6) vs. 6 (5–7),
p = 0.026], and had more often extensive baseline ischemic
changes and bilateral ischemia in baseline imaging. All patients
with acute coma and post-treatment sICH had an mRS 5–6
at 3 months (11 dead and 3 with an mRS of 5). The rate of
TABLE 2 | Factors associated with acute coma in BAO patients.
OR 95% C.I. p
Age (per year) 1.04 1.01–1.06 0.004
CAD 2.18 1.01–4.74 0.049
Convulsions 4.96 2.12–11.61 <0.001
pc-ASPECTS < 8 3.64 1.74–7.62 0.001
Absence of patent PComs 2.44 1.17–5.09 0.018
At least one patent SCA 0.40 0.21–0.75 0.004
Long BAO (≥2 segments) 2.55 1.39–4.67 0.002
CAD, coronary artery disease; pc-ASPECTS, posterior circulation Acute Stroke Prognosis
Early CT Score; PCom, posterior communicating artery; SCA, superior cerebellar artery;
BAO, basilar artery occlusion.
Factors with probability value (p) < 0.1 in a univariate model (Table 1) were included in a
backward stepwise logistic regression model.
recanalization was lower in patients with the worst outcome
(64.0 vs. 88.9%, p = 0.006). Extensive baseline ischemic changes
were a major factor predicting the poorest outcome (mRS 5–6).
In total, 30/103 (29.1%) of the acutely comatose patients had
pc-ASPECTS < 8, and only two of them achieved favorable
outcomes (mRS 0–3). In terms of patients with acute coma and
pc-ASPECTS < 8, 93.3% (28/30) were bedridden or dead (mRS
5–6) after 3 months (Table 5). When patients with pc-APECTS
< 8 were excluded from analysis, 26.0% (19/73) of patients with
initial coma achieved favorable outcome, and 64.4% (47/73) had
an mRS 5–6.
DISCUSSION
Approximately 40% of BAO patients were initially comatose,
which is in line with rates of 30–60% reported in previous studies
(3–10). The main observation of this study was that, despite
the dismal presentation on admission, still 2/10 comatose BAO
patients treated with recanalization therapy reached functionally
meaningful survival. Coma vs. no coma on presentation was
not associated with differences in receiving either IVT or EVT
treatment, nor with the differences in onset to treatment or
symptom to door times. Our data consists of a large cohort
of BAO patients treated in our institution between 1995 and
2019. In view of data from RCTs published in 2015 (20)
demonstrating the efficacy of EVT in large vessel occlusions in
anterior circulation, EVT was adopted in more routine use only
after this in 2015. As previously reported by us (21), our IVT-
treated cohort had comparable outcome rates with many EVT
cohorts, and therefore no evidence-based amendment toward
EVT-based treatment strategy has been made in our written in-
house stroke management guidelines (Figure 2), although the
rates of EVT have increased in recent years.
In our present cohort, older age, a history of coronary artery
disease as a manifestation of atherosclerosis, convulsions at
onset, extensive early ischemia in the vertebrobasilar region,
and a lack of patent collateral vasculature of either circle of
TABLE 3 | Outcome measures between comatose vs. non-comatose patients.
Outcome, n (%) All (n = 259) Non-comatose (n = 156, 60.2%) Comatose (n = 103, 39.8%) p
90-day mRS
mRS 0–2 88 (34.6%) 76 (50.3%) 12 (11.7%) <0.001
mRS 0–3 114 (44.9%) 93 (61.6%) 21 (20.4%) <0.001
mRS 5–6 118 (46.5%) 43 (28.5%) 75 (72.8%) <0.001
Dead at 3 months 98 (38.3%) 37 (24.2%) 61 (59.2%) <0.001
Recanalization (TIMI 2–3)† 155 (75.6%) 98 (76.6%) 57 (74.0%) 0.682
Futile recanalization‡ 61 (30.3%) 23 (18.5%) 38 (49.4%) <0.001
sICH 26 (10.2%) 12 (7.8%) 14 (13.9%) 0.117
†Data available in 79%.
‡Data available in 78%.
mRS, modified Rankin Scale; TIMI, Thrombolysis in Myocardial Infarction; sICH, symptomatic intracerebral hemorrhage.
The outcome was assessed at 3 months. Futile recanalization was determined as successful recanalization but ending up with a poor outcome (modified Rankin Scale 4–6). Symptomatic
intracranial hemorrhage (sICH) was defined according to European Cooperative Acute Stroke Study II (ECASS II) criteria.
Statistically significant p-values (<0.05) are bolded.
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TABLE 4 | Characteristics associated with favorable outcome in comatose BAO patients.
n (%)/median (IQR) All (n = 103) mRS 0–3 (n = 21, 20.4%) mRS 4–6 (n = 82, 79.6%) p
Characteristics
Male sex 63 (61.2%) 14 (66.7%) 49 (59.8%) 0.562
Age 73 (63–79) 65 (57–74) 74 (66–80) 0.010
Diabetes 18 (17.5%) 1 (4.8%) 17 (20.7%) 0.112
Atrial fibrillation 29 (28.2%) 3 (14.3%) 26 (31.7%) 0.113
Hypertension 64 (62.1%) 13 (61.9%) 51 (62.2%) 0.980
Dyslipidemia 42 (40.8%) 6 (28.6%) 36 (43.9%) 0.202
Chronic heart failure 12 (11.7%) 4 (19.0%) 8 (9.8%) 0.259
Coronary artery disease 25 (24.3%) 5 (23.8%) 20 (24.4%) 0.956
Previous myocardial infarction 15 (14.6%) 3 (14.3%) 12 (14.6%) 1.000
Previous stroke 25 (24.3%) 4 (19.0%) 21 (25.6%) 0.531
Sudden onset phenotype 89 (86.4%) 18 (85.7%) 71 (86.6%) 1.000
Prodromes 19 (18.4%) 3 (14.3%) 16 (19.5%) 0.757
Convulsions 25 (24.3%) 5 (23.8%) 20 (24.4%) 0.956
Lowest GCS on admission† 5 (4–6) 6 (4–7) 5 (4–6) 0.212
Radiological parameters
pc-ASPECTS < 8 30 (29.1%) 2 (9.5%) 28 (34.1%) 0.027
Bilateral ischemia 36 (35.3%) 5 (23.8%) 31 (38.3%) 0.217
Brainstem ischemia 24 (23.5%) 3 (14.3%) 21 (25.9%) 0.388
No patent PComs 29 (29.0%) 6 (30.0%) 23 (28.8%) 0.912
2 PComs 43 (43.0%) 10 (50.0%) 33 (41.3%) 0.480
At least one patent PCA 95 (95.0%) 19 (95.0%) 76 (95.0%) 1.000
At least one patent SCA 58 (58.0%) 11 (55.0%) 47 (58.8%) 0.761
Long BAO (≥2 segments) 53 (52.5%) 11 (55.0%) 42 (51.9%) 0.801
BAO exceeding to VA 32 (32.0%) 4 (20.0%) 28 (35.0%) 0.198
Recanalization (TIMI 2–3)‡ 57 (74.0%) 19(95.0%) 38 (66.7%) 0.013
sICH (ECASS II) 14 (13.9%) 0 (0.0%) 14 (17.5%) 0.038
Treatments
IVT 93 (90.3%) 19 (90.5%) 74 (90.2%) 0.974
EVT 30 (29.1%) 5 (23.8%) 25 (30.5%) 0.548
IVT + EVT 21 (20.4%) 3 (14.3%) 18 (22.0%) 0.554
Time delays (min)
OTT 282 (158–640) 247 (165–415) 305 (158–640) 0.595
SDT 158 (85–371) 170 (106–371) 156 (82–371) 0.964
DTN 85 (38–180) 89 (51–165) 85 (38–189) 0.902
†Data available in 81%.
‡Data available in 75%.
mRS, modified Rankin Scale; IQR, interquartile range; GCS, Glasgow Coma Scale; pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early CT Score; PCom, posterior
communicating artery; PCA, posterior cerebral artery; SCA, superior cerebellar artery; BAO, basilar artery occlusion; VA, vertebral artery; TIMI, thrombolysis in myocardial infarction; IVT,
intravenous thrombolysis; EVT, endovascular treatment; OTT, Onset-to-treatment time; SDT, symptom-to-door time; DTN, Door-to-needle time.
Univariate model; a multivariable regression model was not constructed due to the small sample size.
Statistically significant p-values (<0.05) are bolded.
Willis or cerebellum, besides long occlusions, were independently
associated with acute coma in BAO patients. All of these have
a logical neuroanatomical and neurophysiological explanation.
Anatomically, the area vital to upholding consciousness is
the pontine tegmentum, containing the ascending reticular
activating system with a complex network of neurons (1, 11,
22, 23). Cerebrovascular atherosclerosis often leads to occlusions
of the proximal and middle segments of the BA resulting in
pontine ischemia and affecting areas upholding consciousness
(1). Convulsive-like movements and extension rigidity arise
from pontine pyramidal tracts and are therefore suggestive
of brainstem ischemia often involving also areas of reticular
activating circuitry (1, 2). Posterior circulation (Pc) ASPECTS
below 8 correlates well with the brainstem ischemia since 64.6%
of patients with pc-ASPECTS < 8 had brainstem ischemia either
alone or combined with other VB-areas.
The observation that multisegmental occlusions of BA
associated with initial coma are consistent with the probability
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TABLE 5 | Factors associated with poorest outcome (mRS 5–6) in comatose BAO patients.
n (%)/mean (SD)/median (IQR) All (n = 103) mRS 0–4 (n = 28, 27.2%) mRS 5–6 (n = 75, 72.8%) p
Characteristics
Male sex 63 (61.2%) 19 (67.9%) 44 (58.7%) 0.395
Age 71 (12) 65 (14) 73 (10) 0.001
Diabetes n 18 (17.5%) 1 (3.6%) 17 (22.7%) 0.022
Atrial fibrillation 29 (28.2%) 3 (10.7%) 26 (34.7%) 0.016
Hypertension 64 (62.1%) 18 (64.3%) 46 (61.3%) 0.783
Dyslipidemia 42 (40.8%) 9 (32.1%) 33 (44.0%) 0.276
Chronic heart failure 12 (11.7%) 4 (14.3%) 8 (10.7%) 0.731
Coronary artery disease 25 (24.3%) 7 (25.0%) 18 (24.0%) 0.916
Previous myocardial infarction 15 (14.6%) 3 (10.7%) 12 (16.0%) 0.754
Previous stroke 25 (24.3%) 6 (21.4%) 19 (25.3%) 0.681
Sudden onset phenotype 89 (86.4%) 25 (89.3%) 64 (85.3%) 0.753
Prodromes 19 (18.4%) 4 (14.3%) 15 (20.0%) 0.506
Convulsions 25 (24.3%) 7 (25.0%) 18 (24.0%) 0.916
Lowest GCS on admission† 5 (4–6) 6 (5–7) 4 (3–6) 0.026
Radiological parameters
pc-ASPECTS < 8 30 (29.1%) 2 (7.1%) 28 (37.3%) 0.003
Bilateral ischemia 36 (35.3%) 5 (17.9%) 31 (41.9%) 0.023
Brainstem ischemia 24 (23.5%) 3 (10.7%) 21 (28.4%) 0.061
No patent PComs 29 (29.0%) 9 (33.3%) 20 (27.4%) 0.561
2 PComs 43 (43.0%) 13 (48.1%) 30 (41.1%) 0.527
At least one patent PCA 95 (95.0%) 25 (92.6%) 70 (95.9%) 0.610
At least one patent SCA 58 (58.0%) 14 (51.9%) 44 (60.3%) 0.449
Long BAO (≥2 segments) 53 (52.5%) 14 (51.9%) 39 (52.7%) 0.940
BAO exceeding to VA 32 (32.0%) 6 (22.2%) 26 (35.6%) 0.202
Recanalization (TIMI 2–3)‡ 57 (74.0%) 25 (92.6%) 32 (64.0%) 0.006
sICH (ECASS II) 14 (13.9%) 0 (0.0%) 14 (19.2%) 0.010
Treatments
IVT 93 (90.3%) 26 (92.9%) 67 (89.3%) 0.724
EVT 30 (29.1%) 8 (28.6%) 22 (29.3%) 0.940
IVT + EVT 21 (20.4%) 6 (21.4%) 15 (20.0%) 0.873
Time delays (min)
OTT 282 (158–640) 235 (162–379) 315 (158–642) 0.237
SDT 158 (85–371) 159 (98–368) 158 (82–451) 0.961
DTN 85 (38–180) 69 (38–127) 89 (38–214) 0.216
†Data available in 81%.
‡Data available in 75%.
mRS, modified Rankin Scale; SD, Standard deviation; IQR, interquartile range; GCS, Glasgow Coma Scale; pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early CT Score;
PCom, posterior communicating artery; PCA, posterior cerebral artery; SCA, superior cerebellar artery; BAO, basilar artery occlusion; VA, vertebral artery; TIMI, thrombolysis in myocardial
infarction; IVT, intravenous thrombolysis; EVT, endovascular treatment; OTT, Onset-to-treatment time; SDT, symptom-to-door time; DTN, Door-to-needle time.
Univariate model; a multivariable regression model was not possible to construct due to the small sample size.
Statistically significant p-values (<0.05) are bolded.
of a greater number of perforating pontine arteries lacks patency
on presentation. In line with these findings, both Ferbert et
al. (3) and Cross et al. (24) reported a clot location most
often in either proximal or middle segment of BA in comatose
BAO patients. The finding that collateral status associated with
coma on presentation is consistent with the concept of reverse
“backflow” from the PComs and SCAs supplying circulation in
the arterial branches distal to BAOmaintaining brainstem vitality
for longer periods of time (25). Greater collateral status has been
reported to be associated with a better prognosis (26, 27).
The rates of 35 and 45% of good (mRS 0–2) and favorable
outcomes (mRS 0–3), respectively, among the whole BAO
cohort (Table 3) are in line with or slightly better than in
previous cohorts (10, 12, 14, 18, 27–30). Poorer outcomes
were significantly more frequent in comatose patients (Table 3).
Multiple previous studies report unconsciousness as a predictor
of poor outcome (6, 12, 14, 31–33), while others have failed to
demonstrate such correlation reaching statistical significance (4,
5, 9, 10, 24). This might be in part explained by the small number
of study subjects and varying patient selection. When ischemic
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FIGURE 2 | Simplified flow chart on BAO treatment. BAO, Basilar artery
occlusion; OTT, Onset-to-teatment time; IVT, Intravenous thrombolysis;
pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early CT Score;
EVT, Endovascular treatment; LMWH, Low-molecular-weight heparin.
stroke patients requiring ventilation support were analyzed, GCS
< 10 on admission was an independent predictor of both early
and late mortality (34). However, in the present study favorable
outcome (3-month mRS 0–3) was achieved in one-fifth of BAO
patients with initial coma. Similar results have been previously
reported in the BASICS registry with a rate of good outcome
of 17% in intraarterial thrombolysis (IAT) and 26% in IVT
treated BAO patients with coma, tetraplegia, or locked-in state
on presentation (13). In our previous smaller study, we found
a favorable outcome (mRS 0–3) in 22.5% of BAO patients
needing intubation and mechanical ventilation (14). These rates
are slightly higher than those reported by Pallesen et al. (6) with
15.4% of comatose BAO patients achieving a favorable outcome
(mRS 0–3). This might be partly explained with a relatively high
number of patients with no recanalization therapy in their study
since 33% of comatose patients did not receive any recanalization
therapy, 38% underwent IAT, 4% were treated with IVT, and 24%
were treated with IVT+ IAT.
Since reduced consciousness in the case of BAO arises
from brainstem ischemia that might be reversed with rapid
recanalization therapy, it is conceivable that even a patient with
acute coma can be recovered if permanent brainstem tissue
damage remains limited. Indeed, Chandra and coworkers (4)
reported that low GCS scores did not correlate with poor
neurologic outcomes in patients with acute BAO managed with
intraarterial therapy (4). Furthermore, Nagel et al. (9) reported
that lower GCS was associated with less favorable outcome but
when the multivariable model was construed, only pc-ASPECTS
remained as an independent predictor of outcome (9). Similarly,
96% of patients with pc-ASPECTS < 8 at baseline had poor
outcomes (3-month mRS 3–6) in our previous study (35). In the
present study, 93% of patients with acute coma and pc-ASPECTS
< 8 ended up dead or bedridden at 3 months. With further
simulation of the current cohort, it was observed that, when BAO
patients with low pc-ASPECTS were excluded from the analysis,
the rate of favorable outcome raised to 26% within comatose
patients, and the rate of the most devastating outcome of mRS
5–6 reduced to 64% (vs. 72.8%). This supports our present in-
house treatment guideline in which extensive brainstem ischemia
is a contraindication for BAO recanalization treatment but not
coma as such (Figure 2). Since the cohort includes patients also
from a period prior to the European label for IVT use in acute
stroke, the experience and adherence to in-house protocol for
BAO treatment has improved over the years (21).
Besides the absence of ischemic changes, factors associated
with favorable outcomes in comatose BAO patients included
younger age, successful recanalization, and avoiding post-
treatment sICH, the latter two of which are treatment-related
efficacy and safety goals worth further honing. On the other hand,
additional factors associated with the poorest outcome (mRS
5–6) were older age, a burden of cardiovascular comorbidities
(i.e., diabetes and atrial fibrillation), being deeply comatose, and
imaging showing extensive ischemic changes. Although several
of these factors have previously been shown to predict outcome
after BAO (12, 14, 28–30, 36, 37), the relative predictive value
of these factors projecting poor and favorable outcomes of
initially comatose patients has not been described in detail due to
relatively small study populations and cohort sizes of BAO. We
remain with the clinical challenge of weighing each of these in
decision making, taking all of them into consideration in each
BAO patient.
An acutely comatose BAO patient is one of the most
challenging emergencies in neurological ED evaluation. After
the correct diagnosis has been reached, physicians need to
conduct risk stratification to support decision making about
the aggressiveness of the immediate therapy. The prognosis
of BAO without recanalization is abysmal (1, 2), but the rate
of futile recanalization is also high; roughly 50% of comatose
patients in the present study did not avoid institutionalized living
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conditions or death despite success in recanalization. Mortality
among mechanically ventilated stroke patients is known to
be high, yet some of these patients do survive, occasionally
even with no or only slight disability (15). It is known that
physicians tend to be overly pessimistic in predicting survival
and quality of life in patients with severe stroke or other critical
illness and that many physicians’ personal mindsets also affect
their treatment decisions (15). This should be acknowledged in
order to avoid a self-fulfilling prophecy. On the other hand,
novel endovascular recanalization procedures and life-sustaining
therapies in intensive care and stroke units are considerably
expensive when given futilely to reach excellent vascular patency
in patients projected toward a desperate prognosis. Avoiding
sheer mortality should not be the steadfast main goal, and the
probability of meaningful recovery with an acceptable quality
of life should always be kept in mind when making treatment
decisions. Therefore, every evidence-based assistance available is
invaluable for physicians treating these infrequent BAO patients.
This underlines the importance of our present evaluation of
factors that might facilitate the challenging risk stratification and
decision making in the acute setting.
Limitations of the present study are the relatively restricted
number of subjects and the incomplete availability of radiological
recanalization data for all patients, especially the ones with
early clinical deterioration or death within 24 h. Due to
the small number of comatose patients, no multivariable
regression models regarding their outcome were possible to
construe. However, we report data from a previously well-
established single-center cohort of an experienced stroke unit
with a long-honed recanalization therapy protocol for BAO
(5, 7, 14, 21, 30, 35, 38).
In conclusion, one-fifth of BAO patients presenting with
initial coma achieved a favorable outcome within 3 months.
These patients were younger and lacking extensive baseline
ischemic lesions of the vertebrobasilar region on baseline brain
imaging. Therefore, unconsciousness per se and seemingly bleak
clinical conditions upon presentation should not as such exclude
BAO patients from receiving aggressive recanalization therapy.
Rather, initial and post-treatment decisions during subsequent
days should be made individually, considering prognostic key
baseline characteristics, where the volume and location of
infarction should be dominant in assisting maintenance or de-
escalation of intensive care (9, 39). These characteristics can
be brought up in discussions with the closest ones and when
making decisions regarding the prolongation of intensive care
unit treatment.
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